P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA

• M. S. Raab,
• Y. C. Cohen,
• F. Schjesvold,
• K. Aardalen,
• A. Oka,
• A. Spencer,
• M. Wermke,
• P. Hari,
• J. L. Kaufman,
• A. M. Cafro,
• E. M. Ocio,
• N. Doki,
• K. Henson,
• G. Trabucco,
• P.-E. Juif,
• R. Chawla,
• J. Cotton,
• A. Fessehatsion,
• L. Fan,
• J. Blankenship,
• B. Granda,
• H. Lu,
• S. De Vita

Affiliations

M. S. Raab

1 Department of Internal Medicine, Heidelberg University Hospital, Heidelberg, Germany

Y. C. Cohen

2 Tel-Aviv Sourasky (Ichilov) Medical Center

F. Schjesvold

4 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital

K. Aardalen

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

A. Oka

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

A. Spencer

7 The Alfred Hospital, Melbourne, VIC, Australia

M. Wermke

8 NCT/UCC Early Clinical Trial Unit, Universitätsklinikum Carl Gustav Carus an der Technische Universität, Dresden, Germany

P. Hari

9 Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI

J. L. Kaufman

10 Winship Cancer Institute, Emory University, Atlanta, GA, United States of America

A. M. Cafro

11 Department of Hematology, ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy

E. M. Ocio

12 Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain

N. Doki

13 Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan

K. Henson

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

G. Trabucco

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

P.-E. Juif

14 Novartis Institutes for BioMedical Research, Basel, Switzerland

R. Chawla

14 Novartis Institutes for BioMedical Research, Basel, Switzerland

J. Cotton

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

A. Fessehatsion

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

L. Fan

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

J. Blankenship

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

B. Granda

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

H. Lu

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America

S. De Vita

6 Novartis Institutes for BioMedical Research, Cambridge, MA, United States of America